wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Editorial staff
     Editorial board
     For authors
Allergology Review

 Search in articles:
  Authority of Polish Society of Allergology

vol 7. no 2. June 2002  

 Bronchial asthma
Childhood asthma: New insights into management
Joseph D. Spahn, Stanley J. Szefler*

Immunopharmacology Laboratory, Division of Allergy and Immunology, Department of Pediatrics, Nationall Jewish Medical and Research Center, and Department of Pediatrics, University of Colorado Health Sciences Center
*Division of Clinical Pharmacology, Dep

Recently, a concerted effort has been made to reverse the trend of increasing asthma mortality and morbidity. One additional strategy might be to recognize patients at risk for persistent asthma and to intervene early. This review summarizes new information on asthma pathogenesis that has helped shape a new direction in managing childhood asthma. At the core is the recognition that asthma is a chronic inflammatory disease. Subsequently, inhaled steroids, the most potent anti-inflammatory asthma medications, have emerged as the cornerstone of the management of persistent asthma. The recent report of the National Heart, Lung, and Blood Institute’s Childhood Asthma Management Program provides a comprehensive “profile of performance” for 3 treatment choices for the management of persistent asthma. This study answers questions regarding the benefits and shortcomings of the medications evaluated and prompts a closer evaluation of the long-term effects of other treatment strategies, including medications currently being developed. Although intervention with inhaled steroids offers new opportunities to control the development of asthma, one must be cognizant of potential risks in early and long-term therapeutic intervention. This review provides a perspective on our present knowledge, the rationale for early intervention, and opportunity for more aggressive therapy, as well as speculation on how ongoing clinical research will continue to play a role in advancing asthma care and moving toward a “cure” for this life-threatening disease.
Alergia Astma Immunologia, 2002, 8(2), 79-90

keywords: leki rozszerzające oskrzela, astma wieku dziecięcego, Program Leczenia Astmy u Dzieci, kromoglikan sodu, wziewne sterydy, przewlekłe leczenie przeciwzapalne, teofilina, Bronchodilators, childhood asthma, Childhood Asthma Management Program, cromolyn, inha

pages: from 79 to 90

estimated time of download (312 kB)
broadband speed:561282565121024[kbps]

You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.

Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.